Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Figueiredo, Jane C ^a,c   Knight, Julia A ^a,c   Cho, Stewart ^a,c   Savas, Sevtap ^a   Onay, Venus ^a   Briollais, Laurent ^a,c   Goodwin, Pamela J ^a,c   McLaughlin, John R ^a,b,c   Andrulis, Irene L ^a,c   Ozcelik, Hilmi ^a,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINE; GLYCINE; MYC PROTEIN; PROTEIN P27; SERINE; VALINE; CYCLINE; P27 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANADA; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ONSET AGE; OVARY CANCER; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTECTION; PROTEIN DOMAIN; RISK FACTOR; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; GENE FREQUENCY; GENETICS; MIDDLE AGED; MORTALITY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-MYC; RISK FACTORS;

EID: 34447343076     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-99     Document Type: Article

References (29)

1. Deming SL Nass SJ Dickson RB Trock BJ C-myc amplification in breast cancer: A meta-analysis of its occurrence and prognostic relevance Br J Cancer 2000 83 1688-1695 10.1054/bjoc.2000.1522 11104567
2. Alkarain A Slingerland J Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer Breast Cancer Res 2004 6 13-21 314445 14680481 10.1186/bcr722
3. Wirtenberger M Hemminki K Forsti A Klaes R Schmutzler RK Grzybowska E Bermejo JL Wappenschmidt B Bugert P Butkiewicz D Pamula J Pekala W Zientek H Bartram CR Burwinkel B c-MYC Asn11Ser is associated with increased risk for familial breast cancer Int J Cancer 2005 15929079
4. Schondorf T Eisele L Gohring UJ Valter MM Warm M Mallmann P Becker M Fechteler R Weisshaar MP Hoopmann M The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients Tumour Biol 2004 25 306-312 10.1159/000081396 15627896
5. Li G Sturgis EM Wang LE Chamberlain RM Spitz MR El-Naggar AK Hong WK Wei Q Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma Clin Cancer Res 2004 10 3996-4002 10.1158/1078-0432.CCR-04-0089 15217930
6. Chang BL Zheng SL Isaacs SD Wiley KE Turner A Li G Walsh PC Meyers DA Isaacs WB Xu J A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer Cancer Res 2004 64 1997-1999 10.1158/0008-5472.CAN-03-2340 15026335
7. Kibel AS Suarez BK Belani J Oh J Webster R Brophy-Ebbers M Guo C Catalona WJ Picus J Goodfellow PJ CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma Cancer Res 2003 63 2033-2036 12727815
8. Onay VU Briollais L Knight JA Shi E Wang Y Wells S Li H Rajendram I Andrulis IL Ozcelik H SNP-SNP interactions in breast cancer susceptibility BMC Cancer 2006 6 114 1522021 16672066 10.1186/ 1471-2407-6-114
9. Ma H Jin G Hu Z Zhai X Chen W Wang S Wang X Qin J Gao J Liu J Wei Q Shen H Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women Int J Cancer 2006 119 2173-2178 10.1002/ijc.22094 16804901
10. Andrulis IL Boyd NF Sutherland H New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies Can Fam Physician 1997 43 949-950 9154367
11. John EM Hopper JL Beck JC Knight JA Neuhausen SL Senie RT Ziogas A Andrulis IL Anton-Culver H Boyd N Buys SS Daly MB O'Malley FP Santella RM Southey MC Venne VL Venter DJ West DW Whittemore AS Seminara D The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Res 2004 6 R375-89 468645 15217505 10.1186/bcr801
12. Sutherland HJ Lacroix J Knight J Andrulis IL Boyd NF The Cooperative Familial Registry for Breast Cancer Studies: Design and first year recruitment rates in Ontario J Clin Epidemiol 2001 54 93-98 10.1016/ S0895-4356(00)00263-8 11165472
13. Knight JA Sutherland HJ Glendon G Boyd NF Andrulis IL Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies Ann Epidemiol 2002 12 27-33 10.1016/S1047-2797(01)00253-8 11750237
14. Figueiredo JC Knight JA Briollais L Andrulis IL Ozcelik H Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry Cancer Epidemiol Biomarkers Prev 2004 13 583-591 15066923
15. Figueiredo JC Ennis M Knight JA McLaughlin JR Hood N O'Malley F Andrulis IL Goodwin PJ Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study Breast Cancer Res Treat 2006 17115108
16. Figueiredo JC Ennis M Knight JA McLaughlin JR Nicky H O'Malley F Andrulis IL Goodwin PJ Influence of Young Age at Diagnosis and Family History of Breast or Ovarian Cancer on Breast Cancer Outcomes in a Population-Based Cohort Study Breast Cancer Res Treat 17115108
17. Ng PC Henikoff S Accounting for human polymorphisms predicted to affect protein function Genome Res 2002 12 436-446 155281 11875032 10.1101/ gr.212802
18. Ramensky V Bork P Sunyaev S Human non-synonymous SNPs: Server and survey Nucleic Acids Res 2002 30 3894-3900 137415 12202775 10.1093/nar/gkf493
19. Rebbeck TR Ambrosone CB Bell DA Chanock SJ Hayes RB Kadlubar FF Thomas DC SNPs, haplotypes, and cancer: Applications in molecular epidemiology Cancer Epidemiol Biomarkers Prev 2004 13 681-687 15159297
20. Murff HJ Spigel DR Syngal S Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history Jama 2004 292 1480-1489 10.1001/jama.292.12.1480 15383520
21. Gauderman WJ Sample size requirements for association studies of gene-gene interaction Am J Epidemiol 2002 155 478-484 10.1093/aje/ 155.5.478 11867360
22. Therneau TM Grambsch PM Modeling survival data: Extending the Cox model. Statistics for biology and health. New York, Springer-Verlag 2000 62
23. Tomoda K Kubota Y Kato J Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 Nature 1999 398 160-165 10.1038/ 18230 10086358
24. Savas S Ahmad MF Shariff M Kim DY Ozcelik H Candidate nsSNPs that can affect the functions and interactions of cell cycle proteins Proteins 2005 58 697-705 10.1002/prot.20367 15617026
25. Nesbit CE Tersak JM Prochownik EV MYC oncogenes and human neoplastic disease Oncogene 1999 18 3004-3016 10.1038/sj.onc.1202746 10378696
26. Liao DJ Dickson RB c-Myc in breast cancer Endocr Relat Cancer 2000 7 143-164 10.1677/erc.0.0070143 11021963
27. Oster SK Ho CS Soucie EL Penn LZ The myc oncogene: MarvelouslY Complex Adv Cancer Res 2002 84 81-154 11885563
28. Mancuso C Glendon G Anson-Cartwright L Shi EJ Andrulis I Knight J Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire Ann Epidemiol 2004 14 36-43 10.1016/S1047-2797(03)00073-5 14664778
29. Nahta R Takahashi T Ueno NT Hung MC Esteva FJ P27(kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells Cancer Res 2004 64 3981-3986 10.1158/0008-5472.CAN-03-3900 15173011